- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.
This topic will cover the schedules, review of differential diagnosis, nationwide efforts to improve uveitis screening in JIA population, and brief overview of immunosuppressive and biological therapies.
Advanced in clinical and bench research in ophthalmology has produced multiple new treatment options for a variety of ocular diseases. New technology, including the fast growing field of ocular imaging, is been used to further understand eye anatomy and pathology. Progress in the field of ocular surgery has introduced new techniques and better outcomes. The clinical and research environment is complex; issues related to ethics, quality improvement and new technology affect all eye care providers. The Eye Institute has, as one of its mission, the goal of being at the forefront of research, clinical care and education. Our goal is to educate the academic and community eye care providers, residents, researchers and medical students on the best and newest clinical and surgical treatments, cutting edge research and important non-clinical topics available in the field.
- Community eye care professionals
- Full time faculty
- Fellow ophthalmologists
- Ophthalmic photographers
At the conclusion of this activity, I will be able to:
- Review of JIA criteria and its subtypes with attention to uveitis monitoring schedules
- QI strategies to improve uveitis screening in JIA
- Review of immunosuppressive and biological treatments for children with JIA
Judyann Olson, M.D.
Associate Professor - Pediatrics
Medical College of Wisconsin
Judyann Olson, MD
In accordance with the ACCME® Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved